First Time Loading...

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 4.36 USD -0.23% Market Closed
Updated: Jun 1, 2024

ImmuCell Corp
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ImmuCell Corp
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
ImmuCell Corp
NASDAQ:ICCC
Other Current Liabilities
$332.7k
CAGR 3-Years
33%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.3B
CAGR 3-Years
149%
CAGR 5-Years
406%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$648.6m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$516.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%

See Also

What is ImmuCell Corp's Other Current Liabilities?
Other Current Liabilities
332.7k USD

Based on the financial report for Mar 31, 2024, ImmuCell Corp's Other Current Liabilities amounts to 332.7k USD.

What is ImmuCell Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
12%

Over the last year, the Other Current Liabilities growth was 138%. The average annual Other Current Liabilities growth rates for ImmuCell Corp have been 33% over the past three years , 12% over the past five years .